ASH 2016 Expert Roundtable: What Does Emerging CLL Research Mean for Patients?


On location at the 2016 American Society of Hematology (ASH) meeting in San Diego, Patient Power founder Andrew Schorr hosts an expert roundtable, as experts review CLL news from the conference. The panel, including Drs. George Follows, Jeff Sharman and Philip Thompson, explores emerging research, including new data on inhibitors, combination approaches and immunotherapy.

Sponsored by the Patient Empowerment Network through educational grants from AbbVie and Genentech.

Sign in or Register to view comments.